###begin article-title 0
Glycosylation Directs Targeting and Activation of Cystatin F from Intracellular and Extracellular Sources
###end article-title 0
###begin p 1
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
###end p 1
###begin p 2
###xml 697 698 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1065 1073 1065 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
Cystatin F is a cysteine protease inhibitor that is selectively expressed in immune cells and unlike other cystatin family members is targeted to a significant extent to intracellular compartments. Initially made as an inactive glycosylated disulfide-linked dimer, cystatin F is converted to an active monomer by proteolytic cleavage following transport to the endosomal/lysosomal system. This active form of cystatin F targets cathepsin C/DPPI and probably other cathepsins in immune cells. We show that efficient targeting of cystatin F to the endocytic pathway is dependent not on its unique dimeric conformation but rather on its oligosaccharide chains. We demonstrate the unusual addition of N-linked sugars to an Asn-X-Cys motif in cystatin F and provide evidence that the mannose 6-phosphate sorting machinery is used to divert cystatin F from the secretory pathway and to mediate its uptake from extracellular pools. These studies identify a function for the oligosaccharides on cystatin F and raise the possibility that cystatin F might regulate proteases in transby secretion in an inactive form by one cell and subsequent internalization and activation by another cell.
###end p 2
###begin p 3
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 805 808 805 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">(3)</xref>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
The cystatins are a family of naturally occurring cysteine protease inhibitors comprising at least 11 members (1,2). Some are expressed in the cytosol, but the majority are made with signal sequences and enter the secretory pathway. Cystatins have been found in many different body fluids indicating that they have a role in protease regulation in the extracellular milieu. It is thought that cystatins are secreted into the extracellular space to inhibit proteases that may be inadvertently released from cells. However, it is not clear if this is their only or even their major function. Nonetheless, their importance is indicated by the severe phenotypes observed in the absence of some family members. For example, mice lacking cystatin E/M exhibit fatal abnormalities in development of the epidermis (3).
###end p 3
###begin p 4
###xml 230 233 223 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">(4)</xref>
###xml 371 372 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 373 374 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 649 652 642 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">(7)</xref>
The cystatins are structurally well conserved and comprise a single alpha-helix associated with a 5-stranded beta-sheet whose loops combine with residues from the N-terminus to form an 'edge' that engages the protease active site (4). Two cystatin/protease structures have been solved revealing in detail how this part of the 'cystatin fold' engages a cysteine protease (5,6). The primary targets of the cystatins are the papain-related C1 family of cysteine proteases that include enzymes such as cathepsins B, L and S. Some cystatins also inhibit the unrelated cysteine protease, asparagine endopeptidase, but through a distinct structural domain (7).
###end p 4
###begin p 5
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">(10)</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">(11)</xref>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">(12)</xref>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 933 934 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1179 1180 1179 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1181 1182 1181 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 911 916 <span type="species:ncbi:10090">mouse</span>
###xml 926 931 <span type="species:ncbi:9606">human</span>
Cystatin F is an unusual member of the family in several respects. First, it is primarily expressed by immune cells (8,9) where it is often upregulated when these cells undergo differentiation or activation from quiescent precursors. Second, unlike all other family members, cystatin F is initially made as a disulfide-linked dimer (10). Moreover, this dimer is inactive as a protease inhibitor (11) because of mutual steric hindrance by one subunit of the other subunit's ability to bind protease (12). This crucial finding strongly implies that the domain of action of cystatin F is intracellular because the secreted extracellular form is inactive. Consistent with this, a greater proportion of cystatin F is retained within cells compared with cystatin C (9,13). Third, unlike all other cystatins except cystatin E/M and in some instances rodent cystatin C (14,15), cystatin F is glycosylated carrying one (mouse) or two (human) N-linked oligosaccharides. Finally, the amino acids present in the protease-binding loops and N-terminal region of cystatin F are not homologous with those of other family members, indicating that cystatin F might bind distinct protease targets (8,9).
###end p 5
###begin p 6
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 733 737 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
We recently strengthened the notion that cystatin F regulates intracellular rather than extracellular protease activity by showing that a principle target is cathepsin C (16). This enzyme is an important aminopeptidase that activates a variety of serine protease zymogens in the secretory granules of cytotoxic T lymphocytes (CTL), natural killer cells, mast cells and neutrophils (17-19). Although disruption of the cystatin F dimer is sufficient to generate an inhibitor of endopeptidases such as cathepsin L, a proteolytic cleavage event was required to convert inactive cystatin F into an active cathepsin C inhibitor. This cleavage event removes 15 N-terminal residues and also converts dimeric cystatin F into a monomeric form (16). This surprising finding also points to an intracellular domain of action.
###end p 6
###begin p 7
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
How cystatin F is localized within the endocytic pathway when other family members are secreted has not been investigated. Several possibilities might account for its intracellular targeting. For example, the unique dimeric conformation of cystatin F may be important perhaps creating a recognition feature lacking in monomeric cystatins. Alternatively or additionally, one or both of the two canonical N-linked carbohydrate motifs may provide the necessary sorting signals. Third, because cystatin F is only 35% homologous to other family members, there may be other less obvious targeting motifs involved in its intracellular trafficking.
###end p 7
###begin p 8
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 512 513 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 608 609 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 978 986 978 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
Here, we investigate how cystatin F is retained within cells by analysis of cystatin F mutants that either cannot dimerize or lack specific oligosaccharide chains. We show that cystatin F molecules that cannot dimerize are still efficiently targeted to the endosomal system. Moreover, a mutant of cystatin F lacking both canonical N-linked carbohydrate chains was also activated normally within the endocytic pathway. However, this 'non-glycosylated' variant of cystatin F retained sensitivity to treatment with N-glycosidase F (PNGase) because of carbohydrate addition on a cryptic noncanonical (Asn-X-Cys) N-glycosylation site. Either this site, or a neighboring canonical site, sufficed to specify sorting of cystatin F to lysosomal compartments. We further show that cystatin F made and secreted by one cell can be internalized and activated within a different cell through mannose 6-phosphate (M6P)-mediated targeting. Thus, immune cells expressing cystatin F may regulate in transthe protease activity of bystander cells.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Cystatin F dimerization is not required for intracellular targeting
###end title 10
###begin p 11
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 623 632 623 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 787 796 787 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 1017 1026 1017 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 1042 1046 1042 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 1083 1084 1083 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1172 1175 1172 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">(9)</xref>
###xml 1264 1273 1264 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 116 121 <span type="species:ncbi:9606">human</span>
To investigate the trafficking of cystatin F, we generated various mutant forms and analyzed these initially in the human kidney epithelial cell line 293T, which does not express cystatin F. The cells were transfected, and after 48 h, the relative amount of cystatin F in cell lysates (L) and in the culture medium (M) was assessed. Expression of wild-type cystatin F leads to significant secretion of the protein into the culture medium as we and others have previously reported (10,13,16). Nonetheless, a significant amount of cystatin F was also retained in 293T cells and was partially converted to the monomeric form (Figure 1A, left panel). Cystatin F recovered from the culture medium was dimeric, whereas cellular cystatin F comprised a mixture of dimeric and monomeric protein (Figure 1A, left panel). Furthermore, while the dimeric form reacted with antibodies raised against the N-terminus of cystatin F the monomeric form did not, indicating intracellular processing had occurred as we recently reported (Figure 1A, center panel) (16). As shown previously, heterogeneous N-glycosylation accounted for the resolution of distinct forms of cystatin F on SDS-PAGE (9). This is highlighted by the formation of a single form following treatment with PNGase (Figure 1A, right panel).
###end p 11
###begin title 12
Cystatin F subcellular localization and secretion does not depend on dimer formation
###end title 12
###begin p 13
###xml 1328 1329 1327 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1329 1331 1328 1330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">av</sub>
###xml 1332 1335 1331 1334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sup>
###xml 145 150 <span type="species:ncbi:9606">human</span>
A) SDS-PAGE separated cell lysates (L) and culture medium (M) under nonreducing conditions from 293T cells transfected with wild-type or C26,63S human cystatin F. Western blots were probed with an antibody raised against full-length cystatin F (FL Ab) (left and right panels) or an N-terminal peptide (N-term Ab) (center panel). Right panel shows change in mobility following deglycosylation with PNGase under reducing conditions. Open and closed arrowheads denote dimeric and monomeric cystatin F, respectively. Asterisk denotes N-terminal processing of the C26,63S mutant. B) Immunofluorescence microscopy of 293T cells shown in (A) expressing wild-type or C26,63S cystatin F (red) and counterstained with an antibody to the lysosomal marker CD63 (green). Insets demonstrate areas of colocalization at high magnification. Bars, 10 mum. C) Western blot analysis following size exclusion chromatography. Nonreducing SDS-PAGE gel analysis of equal sized aliquots of column fractions obtained following chromatography of wild-type (top panel) or C26,63S (bottom panel) cystatin F. D) The Stokes' radius of wild-type (3.19 nm) and C26,63S (2.35 nm) cystatin F were calculated following size exclusion chromatography. Values were interpolated from the calibration curve obtained by the linear fitting of Stokes' radius versus (-log Kav)1/2 for a series of proteins with known Stokes' radii, as described. Protein calibration was obtained using ribonuclease A (a), carbonic anhydrase (b), ovalbumin (c) and conalbumin (d).
###end p 13
###begin p 14
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">(12)</xref>
###xml 443 452 443 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 690 699 690 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 933 942 933 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
Cystatin F dimerizes through two disulfide bridges involving Cys26 on one subunit and Cys63 on the other (12). We first asked whether intracellular retention of cystatin F was dependent on dimerization by transfecting 293T cells with a cysteine to serine double mutant (C26,63S cystatin F). The expressed protein was monomeric, as expected. Moreover, a similar proportion was retained within the cells when compared with wild-type cystatin F (Figure 1A, left panel), indicating that dimerization is not necessary to divert cystatin F from the secretory to the endocytic pathway. Monomeric cystatin F appeared to be glycosylated normally as judged by its mobility and sensitivity to PNGase (Figure 1A). In addition, a proportion of monomeric cystatin F was N-terminally processed as judged by the reactivity of the fastest migrating form with antibody raised against whole cystatin F but not with the N-terminal-specific N1 antibody (Figure 1A, asterisk).
###end p 14
###begin p 15
###xml 200 209 200 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1B</xref>
To confirm targeting to the endocytic pathway, transfected cells were fixed and stained with antibodies against cystatin F and a marker of the late endosomal/lysosomal compartment (CD63). As shown in Figure 1B, cystatin F partially colocalized with CD63 indicating lysosomal localization. Moreover, C26,63S cystatin F was also colocalized with lysosomal markers.
###end p 15
###begin p 16
###xml 631 640 631 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1C</xref>
###xml 752 761 752 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1C</xref>
###xml 888 898 888 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure1C,D</xref>
Although covalent dimer formation was circumvented by substitution of the two cysteines involved in disulfide bond formation with serine, noncovalent dimer formation was still plausible. In other words, dimerization of C26,63S through noncovalent interaction may account for its lysosomal localization and secretion. To address this, wild-type and C26,63S cystatin F were subject to size exclusion chromatography on a column calibrated with standard proteins of known molecular weight and stokes' radii. Elution of cystatin F was initially followed by absorption (280nm) of the eluted fractions and then confirmed by western blot (Figure 1C). As expected, wild-type cystatin F eluted as a single species and had a calculated stokes' radius of 3.19 nm (Figure 1C, top panel). Likewise, C26,63S cystatin F eluted as a single species but with a smaller calculated stokes' radius of 2.35 nm (Figure1C,D). SDS gel analysis of individual column fractions confirmed that C26,63S cystatin F was included in the column to a much greater extent than wild-type protein. Together, these data indicate that while cystatin F dimerizes, is glycosylated and a proportion is targeted to the endocytic pathway in 293T cells, dimerization is not necessary for these post-translational modifications or for its targeting.
###end p 16
###begin title 17
Noncanonical Asn-linked glycosylation can occur on cystatin F
###end title 17
###begin p 18
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 848 857 848 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2A</xref>
###xml 1486 1488 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 1489 1491 1489 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1506 1515 1506 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2B</xref>
###xml 1880 1889 1880 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2C</xref>
###xml 1905 1907 1905 1907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">61</sup>
###xml 1913 1915 1913 1915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sup>
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 204 210 <span type="species:ncbi:10090">murine</span>
###xml 287 293 <span type="species:ncbi:9606">humans</span>
###xml 324 329 <span type="species:ncbi:9606">human</span>
We next assessed the possibility that glycosylation of cystatin F was important for targeting the endosomal/lysosomal system. In human cystatin F asparagines 62 and 115 carry carbohydrate chains, whereas murine cystatin F carries a single N-linked sugar at a site homologous to Asn62 in humans. We generated mutant forms of human cystatin F where one or both Asn residues were altered to Ser (N62S, N115S and N62,115S) and transfected these into 293T cells. Culture medium and cell lysates were then analyzed for the presence of cystatin F and digested with PNGase to assess its glycosylation status. Similar to wild-type cystatin F, all mutant forms of cystatin F migrated as a single band following treatment with PNGase. Puzzling, however, the gel mobility of the N62S mutant in the absence of PNGase digestion was similar to that of wild type (Figure 2A). Even more surprising is that the double mutant N62,115S, which we predicted would not be glycosylated, migrated as two species, one of which retained sensitivity to digestion with PNGase. Because N62 and N115 are the only Asn residues found in a conventional Asn-X-Thr/Ser glycosylation consensus sequence, these results pointed to the existence of an unusual glycosylation site on cystatin F. Glycosylation of Asn residues in the context an atypical Asn-X-Cys sequence has previously been observed, for example in the recombinant epidermal growth factor receptor, the T-cell activation antigen CD69 and a few other proteins (20,21). As shown in Figure 2B, Asn61 of cystatin F also occurs in this context. We therefore tested the hypothesis that mutagenesis of Asn62 might reveal a cryptic noncanonical glycosylation site at Asn61. Consistent with this possibility, the double mutant N61,62S now expressed a single PNGase-sensitive product, and the triple mutant N61,62,115S was fully resistant to the action of PNGase (Figure 2C). Thus, the Asn61-X-Cys63 sequence in cystatin F can be used by the glycosylation machinery.
###end p 18
###begin title 19
###xml 39 40 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
Mutagenesis of consensus sequences for N-linked glycosylation reveals an atypical glycosylation site
###end title 19
###begin p 20
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 241 246 <span type="species:ncbi:9606">Human</span>
A) Reducing SDS-PAGE analysis of mutants of one (N62S or N115S) or both (N62,115S) N-linked glycosylation sequences. Remaining glycosylation of cystatin F (Cyst. F) is revealed by comparing untreated samples (-) to PNGase treatment (+). (B) Human cystatin F amino acid residues 61-63 (NXC) represent a potential atypical N-linked glycosylation site. (C) Reducing SDS-PAGE comparing glycosylation of double (N61,62S) and triple (N61,62,115S) Asn mutants in the presence (+) or absence (-) of PNGase. Representative cell lysates (Lys) and culture medium (Med) are shown. (D) Immunofluorescence microscopy following transfection of 293T cells (as in C) with antibodies raised against full-length cystatin F (red) and markers of lysosomes (CD63) or the trans-Golgi network (TGN46) (green). Insets reveal areas of costaining. Bars, 10 mum.
###end p 20
###begin title 21
Glycosylation of either Asn61 or Asn62 is required for cystatin F targeting to endosomes
###end title 21
###begin p 22
###xml 271 279 271 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure2C</xref>
###xml 415 424 415 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2D</xref>
###xml 538 547 538 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figure S1</xref>
###xml 639 644 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 705 714 705 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2D</xref>
###xml 827 828 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
Analysis of the trafficking of the Asn61 mutant produced another important result. Whereas the N62,115S mutant was still targeted to intracellular compartments (data not shown), the N61,62S mutant and the triple mutant were largely absent and found mostly in the medium (Figure2C). Consistent with this, we could not detect colocalization of the N61,62S or N61,62,115S mutant with markers of the lysosomal pathway (Figure 2D). Moreover, in contrast to cells expressing wild-type and N115S mutants, cathepsin C activity was not inhibited (Figure S1). Instead, any cystatin F remaining within these cells colocalized with the markers of the trans-Golgi network indicative of protein destined for secretion (Figure 2D). These results indicate that glycosylation of cystatin F is important for its intracellular targeting and that N-linked glycans on either Asn61 or Asn62 are required. In contrast, glycosylation of Asn115 does not appear to be involved in the intracellular targeting of cystatin F.
###end p 22
###begin title 23
Mannose 6-phosphorylation is used to target cystatin F to endosomes
###end title 23
###begin p 24
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">(22)</xref>
###xml 427 436 427 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3A</xref>
###xml 470 472 470 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 560 561 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 671 673 668 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1116 1125 1113 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3B</xref>
###xml 1240 1249 1237 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3B</xref>
###xml 792 797 <span type="species:ncbi:10090">mouse</span>
Many lysosomal hydrolases carry N-linked glycans that become modified with M6P and use the cation-dependent or -independent M6P receptors (CD-MPR or CI-MPR, respectively) for targeting the endocytic pathway (22). We asked whether cystatin F might also utilize the M6P system to reach endosomes and lysosomes. First, we looked for evidence that one or more of the oligosaccharides on cystatin F were phosphorylated. As shown in Figure 3A, cystatin F became labeled with [32P] orthophosphate in 293T cells, and this label was removed by treatment with endo-beta-N-acetylglucosaminindase H (EndoH), suggesting phosphorylation occurred on high mannose glycans. In contrast, [35S]-labeled cystatin F migrated faster following treatment with EndoH, but the label was not removed. Next, we infected mouse fibroblasts, including those lacking the CI-MPR, with a retrovirus expressing wild-type cystatin F. Whereas L929 cells, which express wild-type levels of both MPR, retained a proportion of cystatin F and converted it to the monomeric form, no intracellular cystatin F could be detected in L cells lacking the CI-MPRs (Figure 3B). Cystatin F retention and N-terminal processing were restored in knockout L cells reconstituted with the CI-MPR (Figure 3B).
###end p 24
###begin title 25
Cellular retention of cystatin F requires the CI-MPR
###end title 25
###begin p 26
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 389 394 <span type="species:ncbi:9606">human</span>
A) 293T cells transfected with wild-type cystatin F were radiolabeled with [32P] orthophosphate (left panel) or [35S] methionine/cysteine (right panel). Labeled cystatin F in postnuclear lysates (Lys) and culture medium (Med) were immunoprecipitated and either left untreated (-) or treated with EndoH (+) followed by SDS-PAGE under reducing conditions. B) Retrovirus containing wild-type human cystatin F was used to infect L929 cells, L cells lacking the CI-MPR (CI-MPR KO) or the CI-MPR KO reconstituted with the CI-MPR (KO+CI-MPR). Cystatin F in cell lysates (L) and culture medium (M) was detected by western blot using the FL Ab following SDS-PAGE under nonreducing conditions. Open and closed arrowheads denote dimeric and monomeric cystatin F, respectively. Actin staining is used to show equivalent protein loaded.
###end p 26
###begin title 27
Cellular acquisition of exogenous cystatin F
###end title 27
###begin p 28
###xml 489 497 489 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
The itinerary of the CI-MPR is known to include the cell surface and many studies have demonstrated its ability to mediate internalization of extracellular M6P-tagged enzymes. Our finding that intracellular targeting of cystatin F could use the M6P system raised the possibility that secreted cystatin F might enter cells using the same system. More generally, the internalization and subsequent activation of inactive dimeric cystatin F would in principle allow proteases to be regulated in trans, that is in cells not expressing cystatin F.
###end p 28
###begin p 29
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 299 308 299 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4A</xref>
###xml 592 601 592 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4A</xref>
###xml 734 743 734 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4A</xref>
###xml 1023 1027 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 1055 1064 1051 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4B</xref>
###xml 1079 1087 1075 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure4C</xref>
###xml 1251 1260 1247 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4C</xref>
###xml 1587 1596 1583 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4D</xref>
###xml 1888 1897 1884 1893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4E</xref>
We first asked whether cystatin F secreted by 293T cells could be taken up by other cells and if so whether internalization was dependent on cystatin F glycosylation. We collected the culture medium from 293T cells transfected with the various N-glycosylation mutants of cystatin F described above (Figure 4A, left panel) and incubated these conditioned media with L929 cell monolayers. After 48 h, the recipient cells were tested for internalization and processing of cystatin F. L929 cells not only acquired wild-type cystatin F but also converted the inactive dimer to the monomeric form (Figure 4A, right panel). Although N115S cystatin F was also taken up by L929 cells, the N61,62S and N61,62,115S forms of cystatin F were not (Figure 4A). The internalization of cystatin F glycan mutants N62S or N62,115S further confirmed the requirement of glycosylation at one of these important residues. Surprisingly, monomeric cystatin F (C26,63S) and a mutant mimicking the N-terminally processed cystatin (DeltaN cystatin F) (16) failed to be internalized (Figure 4B). As shown in Figure4C, C26,63S cystatin F, like wild-type cystatin F, still acquired EndoH-sensitive phosphate residues indicating that monomeric cystatin F was also modified with M6P (Figure 4C). These data suggest that in addition to glycosylation of N61 or N62, a dimeric and presumably dually phosphorylated protein must be present. We confirmed these results by immunofluorescence microscopy. Wild-type and N115S cystatin F, but not N61,62S or N61,62,115S cystatin F, were taken up and became colocalized with CD63 (Figure 4D). Importantly, internalized cystatin F became active as a protease inhibitor within the recipient cells because endogenous cathepsin L and cathepsin C activity was suppressed. In contrast, there was no inhibition of these proteases in cells incubated with N61,62S or N61,62,115S cystatin F (Figure 4E).
###end p 29
###begin title 30
Secreted cystatin F can be internalized in a carbohydrate-dependent manner
###end title 30
###begin p 31
###xml 859 861 855 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 896 898 892 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
A) Equal concentrations of secreted wild-type and glycosylation mutant cystatin F (Cyst. F) produced by 293T cells (left panel) were cultured with L929 cells for 48 h. L929 cell lysates were separated by SDS-PAGE under nonreducing conditions with membranes immunoblotting for internalized cystatin F using the indicated antibody (center and right panel). B) Equal concentrations of secreted glycosylation mutants (N62S and N62,115S) and mutants rendering cystatin F monomeric (C26,63S and DeltaN cystatin F) produced by 293T cells (left panel) were cultured with L929 cells as described in (A) and were stained with the FL Ab (right panel). Cystatin F dimeric species (open triangles) and monomeric species (closed triangles) are shown. Actin staining indicates equal protein loading. C) 293T cells transfected with C26,63S cystatin F were radiolabeled with [32P] orthophosphate (left panel) or [35S] methionine/cysteine (right panel). Labeled cystatin F in postnuclear lysates (Lys) and in the culture medium (Med) were immunoprecipitated using the cystatin F polyclonal antibody and either left untreated (-) or were treated with EndoH (+) followed by SDS-PAGE under reducing conditions. D) Immunofluorescent labeling of internalized cystatin F (red) in L929 cells and the lysosomal marker CD63 (green). Insets demonstrate areas of colocalization at high magnification. Bars, 10 mum. (E) Cathepsin activities in 293T cells (cathepsin C; light gray) and L929 cells (cathepsin L; dark gray) exposed to cystatin F-conditioned medium. Data represent the mean rate of more than three independent experiments. Error bars indicate the SEM. Significant differences of *p < 0.02 and **p < 0.005.
###end p 31
###begin p 32
###xml 212 221 212 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figure 5A</xref>
###xml 324 325 324 325 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 384 396 384 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figures 5A,B</xref>
###xml 519 528 519 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD2">Figure S2</xref>
###xml 898 907 898 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figure 5C</xref>
###xml 1192 1201 1192 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figure 5C</xref>
###xml 1417 1425 1417 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figure5D</xref>
###xml 647 652 <span type="species:ncbi:10090">mouse</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
To establish whether the glycosylation-dependent internalization of cystatin F utilized the M6P system, we repeated the internalization experiment in the presence of increasing concentrations of M6P. As shown in Figure 5A, accumulation of monomeric cystatin F by L929 cells was significantly blocked in the presence of 0.5 mmM6P and almost completely by higher concentrations of M6P (Figures 5A,B). This blockade was specific for M6P as pretreatment with mannose or fucose failed to inhibit cystatin F internalization (Figure S2). However, there was a small fraction of dimeric cystatin F associated at these concentrations of M6P. We also tested mouse embryonic fibroblasts (MEF) isolated from either wild-type or MPR knockout mice. Whereas monomeric cystatin F accumulated in wild-type MEF and in knockout MEF reconstituted with the CI-MPR, knockout MEF themselves accumulated much less monomer (Figure 5C). As in the presence of M6P, a fraction of dimeric cystatin F continued to associate with these cells as did some faster migrating cystatin F. However, this cystatin F did not co-migrate with the monomer taken up by wild-type cells, although it appeared to be N-terminally processed (Figure 5C, center and right panel). To examine whether the residual cystatin F association with cells devoid of MPR was carbohydrate dependent, we exposed wild-type and knockout MEFs to unglycosylated cystatin F. As shown in Figure5D, internalization of N61,62,115S cystatin F was completely blocked irrespective of the presence or absence of the MPR. These results show that internalization and activation of cystatin F is at least partially dependent on the MPR system and is completely dependent on glycosylation of cystatin F.
###end p 32
###begin title 33
Internalization and activation of cystatin F is dependent on the CI-MPR
###end title 33
###begin p 34
###xml 191 192 191 192 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 421 424 415 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 514 535 508 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Materials and Methods</italic>
###xml 230 235 <span type="species:ncbi:9606">human</span>
A) L929 cells cultured in media conditioned by cystatin F-transfected 293T cells (represented in the left panel) in the absence or presence of decreasing concentration of free M6P (5.0-0.05 mmfinal). B) [125I]-labeled recombinant human cystatin F was cultured with L929 cells in the presence or absence of free M6P for 30 min at 37degreesC. The percent of cystatin F internalized was measured by comparing surface bound [125I]-labeled cystatin F at 0 min with internalized cystatin F at 30 min as described in the Materials and Methods. C) Cystatin F-containing medium (left panel) was cultured with wild-type MEF, MPR knockout MEF (MPR KO) or in fibroblasts reconstituted with only the CI-MPR. Left and center panels display gels probed with the FL Ab. Right panel shows MEF lysates probed with the N-term Ab. D) Unglycosylated cystatin F (N61,62,115S)-containing medium (left panel) was cultured with either wild-type MEFs, MPR KO MEFs or in reconstituted MEFs (right panel). Western blots were probed with the FL Ab. All gels were run under nonreducing conditions. Open and closed arrowheads denote dimeric and monomeric cystatin F, respectively. Actin staining is used to show equivalent total protein loaded.
###end p 34
###begin title 35
Cystatin F production and internalization by immune cells
###end title 35
###begin p 36
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 405 414 405 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Figure 6A</xref>
###xml 572 573 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 585 593 585 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 666 667 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 848 849 848 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 879 880 879 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 889 898 889 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Figure 6B</xref>
###xml 924 933 924 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Figure 6C</xref>
###xml 963 964 963 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1117 1126 1117 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Figure 6C</xref>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
Finally, we asked whether secretion of cystatin F by one cell and internalization by another could be demonstrated in primary immune cells. We found that significant amounts of dimeric cystatin F were secreted from primary CD8+ T lymphocytes and bone marrow-derived dendritic cells (BMDC). As expected, the cell lysates also contained cystatin F, much of which was converted to the active monomeric form (Figure 6A). We recently generated cystatin F-deficient mice that are currently being analyzed. These mice were used to generate a population of cystatin F-negative CD8+ T cells by in vitroexpansion. We incubated these cells with an equal number of wild-type CD8+ T cells and asked whether cystatin F was acquired by the null cells. We used the CD45 marker and fluorescence-activated cell sorter (FACS) analysis to distinguish wild type (CD45.1+) from cystatin F null (CD45.2+) cells (Figure 6B, top panel). As shown in Figure 6C, a small proportion of CD45.2+ cells became positive for cystatin F during the course of the experiment demonstrating that the protease inhibitor had been taken up by the null cells (Figure 6C, bottom panel). This important result indicates that one cell may influence the protease activity of another through the agency of cystatin F.
###end p 36
###begin title 37
Internalization and activation of cystatin F in primary cells
###end title 37
###begin p 38
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 510 511 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 595 596 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 707 708 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 52 58 <span type="species:ncbi:10090">murine</span>
A) Lysates (L) and medium (M) from cultured primary murine CD8+ T lymphocytes (CTL) and dendritic cells (BMDC) isolated from spleen and bone marrow, respectively. B) Lysates from activated CD45.1+ (wild type) and CD45.2+ (knockout) CTLs were separated by nonreducing SDS-PAGE and immunoblotted for cystatin F (Cyst. F). Arrowheads denote dimeric (open) and monomeric (closed) cystatin F. Actin staining is used to confirm equivalent protein loading. C) CD45.1+ wild-type splenocytes were cocultured with CD45.2+ cystatin F knockout splenocytes for 48 h. Internalization of cystatin F into CD45.2+ cells was determined by intracellular immunostaining (after coculture). Numbers represent percentage of CD45.2+ cells staining for cystatin F before and after coculture. FACS data are representative of at least three independent experiments.
###end p 38
###begin p 39
###xml 803 815 803 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD4">Figure S4A,B</xref>
###xml 977 987 977 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD4">Figure S4C</xref>
We sought to determine whether internalized cystatin F was active in recipient primary T cells. However, it was not feasible to analyze proteolytic activity in the relatively small number of cells that had acquired cystatin F because their identification necessitated fixation and permeabilization before FACS analysis. To establish that protease activity in primary T cells can be attenuated by exogenous cystatin F, we cultured cystatin F knockout splenocytes with recombinant cystatin F for 48 h and followed its internalization by intracellular FACS analysis and microscopy. A parallel culture was then lysed and cathepsin C protease activity was analyzed in the cystatin F-treated and untreated populations. Internalization of cystatin F under these conditions resulted in its proper localization (Figure S4A,B). Moreover, although not all T cells acquired cystatin F, cathepsin C activity in the bulk population was substantially reduced in the cystatin F-exposed cells (Figure S4C), demonstrating that internalized cystatin F was active. This result further indicates that cystatin F secreted by one cell may attenuate protease activity in another cell.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">(12)</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
The mechanism of action of cystatin F appears to constitute a new paradigm for regulation of protease activity in the endocytic pathway. Following biosynthesis, its activity is quenched because of its unique dimeric conformation (12). Some of this form is secreted from cells but a substantial proportion is targeted to the endocytic pathway where proteolysis converts the dimer to active monomers. In immune cells, this form inhibits cathepsin C/DPPI and probably other cathepsins (16). The existence of a protease-activated protease inhibitor clearly suggests a novel mechanism for feedback attenuation of protease activity in the endocytic pathway. How cystatin F is targeted to the endocytic pathway is an important and unresolved issue that we investigated here.
###end p 41
###begin p 42
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 598 601 598 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">(9)</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">(13)</xref>
###xml 1005 1009 1005 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 1233 1237 1233 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 1387 1389 1387 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 1390 1392 1390 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
Most cystatins made with signal sequences (type II cystatins) are secreted from cells, suggesting that their primary function is to inactivate potentially dangerous proteases that have been secreted or lost from cells into the extracellular space thereby protecting from inflammatory reactions associated with aberrant release of these proteases (23-25). While cathepsins have been shown to be secreted from cells and have been shown to exhibit protease activity at neutral pH (26-28), their inhibition by secreted cystatins has not been demonstrated. Cystatin F has also been shown to be secreted (9); however, recent data suggest that the primary targets for cystatin F are intracellular. First, the relative concentration of cystatin F within cells compared with that which is secreted is much higher than for the other type II family members (13). Second, our recent findings suggest that one of the true physiological targets of cystatin F is cathepsin C, which is found in the endocytic compartment (16). Inhibition of this aminopeptidase requires that cystatin F undergoes an N-terminal proteolytic processing step occurring in intracellular compartments where protease activity and its cathepsin targets are likely to reside (16). Third, cystatin F is secreted as an inactive disulfide-linked dimer, and to date, the active monomeric form has only been observed intracellularly (11,16). Together, these data suggest that cystatin F inhibitory activity is restricted to the endocytic compartment.
###end p 42
###begin p 43
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">(29)</xref>
The mechanism by which cystatin F is retained within cells and matured in the endocytic compartment is addressed here. We demonstrate that dimerization is not necessary for intracellular cystatin F to be directed to the lysosomal pathway but rather a carbohydrate-dependent sorting mechanism operates. Our findings provide an explanation for why cystatin F is glycosylated when almost all other family members are not. Cystatin M/E is also glycosylated and is found in the lamellar granules of the cells of the stratum granulosum of the skin as well as in extracellular locations (29). Whether localization of cystatin M/E in these granules also depends on its glycosylation is not known.
###end p 43
###begin p 44
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">(30)</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
To our knowledge, cystatin F is the first lysosomal protease inhibitor shown to be M6P modified. This appears to be integral for proper targeting to the lysosomal compartment as judged by the failure of cells lacking MPRs to retain cystatin F. An earlier report identified cystatin F as one of several secreted proteins recovered from an MPR column, although it was not clear if the association was direct or indirect, for example through a binding partner modified with M6P (30). Our data indicate that binding to the MPR column was most likely direct. Studies in cells derived from mice lacking both 46 and 300 kD MPRs demonstrate that some cell types have additional mechanisms for intracellular targeting of lysosomal hydrolases (31,32). It is possible that cystatin F also utilizes such mechanisms depending on cell type.
###end p 44
###begin p 45
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 208 217 208 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD3">Figure S3</xref>
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 659 668 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD3">Figure S3</xref>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1056 1058 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1059 1060 1059 1060 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 81 87 <span type="species:ncbi:10090">murine</span>
###xml 1033 1038 <span type="species:ncbi:9606">human</span>
Human cystatin F carries two N-linked oligosaccharides at Asn62 and 115, whereas murine cystatin F lacks the second sugar. Consistent with conservation of glycosylation at position 62 in mammalian cystatins (Figure S3), we show that this sugar carries targeting information, whereas the Asn115-linked sugar does not. Surprisingly, elimination of both Asn62 and 115 revealed a cryptic N-linked glycosylation site at Asn61, which utilized the noncanonical motif Asn-X-Cys-Ser/Thr and which sufficed to target cystatin F correctly in the absence of the canonical Asn62-linked sugar. The Asn61 residue is conserved in all cystatin F sequences deposited thus far (Figure S3). Other proteins have been shown to direct glycans at sites containing cysteine rather than serine or threonine at the third position. Like cystatin F, several include atypical sequences where a serine or threonine residue at the fourth position in conjunction with a cysteine at the third position (NXCS/T) is present. These include the immune regulator CD69 and human protein C (20,21,33).Whether Asn61 and Asn62 are both modified in wild-type cystatin F is not yet clear. Because the cysteine residue (C63) in the Asn-X-Cys motif is involved in the dimerizing disulfide bond, presumably recognition of the motif and addition of core oligosaccharide to Asn61 must occur before dimerization and loss of the free thiol. However, this has not been formally demonstrated.
###end p 45
###begin p 46
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">(12)</xref>
###xml 653 660 653 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
High concentrations of reducing agents are required to reduce the cystatin F dimer making a proteolytic mechanism for monomerization more likely and linking cystatin F activation to endosomal proteolytic activity rather than reducing potential (11,16). Based on the crystal structure of cystatin F, we suggested earlier that an additional function for the oligosaccharide at Asn62 (and perhaps Asn61) may be to shield the disulfide bonds linking the monomers (12). However, as cystatin F lacking oligosaccharides at Asn61 and Asn62 is secreted, this remains a hypothesis because we are unable to assess whether this dimer is more sensitive to reduction in vivo.
###end p 46
###begin p 47
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">(34)</xref>
###xml 1003 1007 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">(35)</xref>
###xml 1344 1346 1344 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 1453 1455 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 1456 1458 1456 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 1554 1556 1554 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1557 1559 1557 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 1776 1780 1776 1780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">(43)</xref>
###xml 1832 1836 1832 1836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">(44)</xref>
###xml 1720 1725 <span type="species:ncbi:9606">human</span>
Sequestration of cystatin F from the secretory pathway by an M6P/MPR mechanism raised the possibility that secreted dimeric cystatin F might be taken up into cells using the same system, as first described by Neufeld and colleagues for lysosomal enzymes (34). We found that different cell lines and primary cells were able to internalize inactive dimeric cystatin F and convert it to its active monomeric form. Moreover, this internalization and conversion was inhibited by free M6P sugar and was reduced in cells lacking MPRs. Importantly, we could demonstrate suppression of protease activity in the recipient cell as well as exchange of cystatin F between immune cells. We noticed that secreted monomeric cystatin F was not internalized although, like wild-type cystatin F, it was phosphorylated on high mannose glycans and was targeted to lysosomes during biosynthesis. Conceivably, the increased avidity provided by two M6P modified sugars in the dimer for the CI-MPR accounts for this observation (35). It is also important to note that soluble monomeric M6P could not completely suppress cystatin F internalization into L929 cells, and consistent with this, some internalization still occurred in cells lacking MPRs. However, additional mechanisms for targeting secreted lysosomal enzymes exist such as the multiligand receptor megalin (36,37); carbohydrate-specific-binding lectins such as the galactose-, fucose- and mannose-binding receptors (38-40) and glycosaminoglycan (GAG)-binding receptors such as CD44 and the hyaluronic acid receptors (41,42), among others. It is possible that one or more of these mechanisms contribute to cystatin F targeting and endocytic uptake. Indeed, a recent report shows that human cystatin C, which is monomeric and unglycosylated (43), can be taken up by cells via an unknown mechanism (44). However, the role of carbohydrates associated with cystatin F is highlighted by the fact that unglycosylated cystatin F was not internalized by target cells. Furthermore, in the absence of M6P targeting, most endocytosed cell-associated cystatin F remained in the dimeric form, suggesting that efficient transport to the compartment where proteolytic conversion occurred required the M6P/MPR system.
###end p 47
###begin p 48
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 774 781 774 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1048 1052 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">(45)</xref>
###xml 1102 1109 1102 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1215 1219 1215 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">(36)</xref>
###xml 1296 1303 1296 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
These results raise the possibility that immune cells secreting cystatin F may be able to regulate protease activity in neighboring cells that either do not express cystatin F or express insufficient levels. Cystatin F expressing primary cell populations such as CD8+ T cells often show heterogeneous levels of expression. Therefore, secretion and internalization of cystatin F in the closely confined in vivomilieu may even out these differences in expression. Cystatin F may be transferred efficiently from one cell to another not only because of its M6P tag but also because, unlike other cystatins found in the external milieu, it is unable to bind protease targets and therefore will not be sequestered by extracellular cysteine proteases. Several precedents exist for in vivoacquisition of lysosomal enzymes by one cell type following secretion by another. For example, cathepsin L-deficient thymocytes acquired this enzyme from surrounding epithelial cells rescuing a defect in antigen presentation and development of natural killer T cells (45). In another example, procathepsin B was taken up in vivofrom the glomerular filtrate into kidney proximal tubule cells and reconstituted a cathepsin B deficiency (36). Although we have not yet demonstrated transfer of cystatin F between cells in vivo, our results clearly indicate that this may take place. Conceivably, given that cathepsin C is one of the targets of cystatin F, this may be a way of attenuating granule protease-driven inflammatory reactions.
###end p 48
###begin p 49
###xml 280 288 280 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Figure 7</xref>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
In summary, our study sheds light on the unusual features of the cystatin F molecule. Glycosylation and more specifically M6P modification serve to target it to the endocytic pathway during biosynthesis, and for a proportion of molecules, by endocytosis from the external medium (Figure 7). In the event when Asn62 is not modified, a 'backup' noncanonical N-linked M6P-modified sugar can be added to Asn61. Although the dimeric form is not crucial for intracellular targeting, it appears to be necessary for endocytic uptake. Moreover, dimerization ensures the latency of the inhibitor, which only becomes active following activation by proteases. The possibility that cystatin F is activated by the same protease systems that it inhibits is currently under investigation.
###end p 49
###begin title 50
Proposed model describing the requirement of cystatin F glycosylation for intracellular targeting and internalization
###end title 50
###begin p 51
Cystatin F is synthesized as an inactive glycosylated disulfide-linked dimer. M6P modified glycans direct cystatin F to lysosomes where N-terminal proteolysis induces its activation (processed cystatin F). A proportion of inactive dimeric cystatin F is secreted where it binds membrane receptors, such as the CI-MPR, on adjacent cells. Internalization of cystatin F leads to a M6P-dependent lysosomal localization where N-terminal processing results in its activation.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Chemical reagents
###end title 53
###begin p 54
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 177 183 <span type="species:ncbi:9986">Rabbit</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
###xml 351 356 <span type="species:ncbi:10090">Mouse</span>
###xml 393 398 <span type="species:ncbi:9940">Sheep</span>
###xml 485 490 <span type="species:ncbi:10090">Mouse</span>
Cell culture media were purchased from Gibco unless otherwise indicated. H-Gly-Phe-AMC and Z-Phe-Arg-AMC were purchased from Bachem. PNGase and EndoH were purchased from Roche. Rabbit polyclonal antibodies directed against full-length human cystatin F (FL Ab) or against an N-terminal peptide (aa20-35; N-term Ab) have been described previously (16). Mouse anti-CD63 was purchased from Abcam. Sheep anti-TGN46 antibody was a kind gift from Dr S. Ponnambalam (University of Leeds, UK). Mouse monoclonal actin antibody was purchased from Sigma-Aldrich. All secondary antibodies used for western analysis were purchased from Jackson Laboratories. Antigen-presenting cell (APC)-conjugated CD45.2, CD8 and CD11c were purchased from eBioscience. Quik Change Site-Directed Mutagenesis kit was purchased from Stratagene. Protein standards for determination of stokes' radii were obtained from GE Healthcare.
###end p 54
###begin title 55
Cell culture
###end title 55
###begin p 56
###xml 100 101 100 101 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 101 102 101 102 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 676 680 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">(46)</xref>
###xml 705 706 704 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 823 825 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 826 828 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 843 844 842 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 852 853 851 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 79 83 <span type="species:ncbi:9913">calf</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
The cell lines 293T and L929 were cultured in DMEM supplemented with 10% fetal calf serum (FCS), 2 mml- glutamine, 100 U/mL penicillin and 100 mug/mL streptomycin. L cells devoid of the CI-MPR (CI-MPR KO), and those reconstituted with the CI-MPR (KO + CI-MPR) were kindly provided by T. Braulke (University Hospital Hamburg, Germany) and were cultured in the same medium as L929 cells. Wild-type MEF, MPR knockout fibroblasts and those reconstituted with the human CI-MPR were generous gifts from R. Pohlmann (Westfalische Wilhelms-Universitat Munster, Germany) and B. Hoflack (Biotechnological Center, Technical University of Dresden, Germany) and were cultured as described (46). Dendritic cells and CD8+ T lymphocytes were cultured from the bone marrow and spleen, respectively, of C57BL/6 mice as described previously (16,47). C57Bl6-Ly5.1+ (CD45.1+) mice were a kind gift from P. Crocker (University of Dundee, UK). Cystatin F knockout mice were generated under contract by Artemis Pharmaceuticals GmbH and will be fully described elsewhere.
###end p 56
###begin title 57
Site-directed mutagenesis and deglycosylation of cystatin F
###end title 57
###begin p 58
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 441 444 441 444 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCC</underline>
###xml 497 500 497 500 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGA</underline>
###xml 546 552 546 552 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGCTCC</underline>
###xml 605 611 605 611 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGAGCT</underline>
###xml 651 654 651 654 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGC</underline>
###xml 719 722 719 722 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCT</underline>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Mutagenesis was performed using plasmids encoding full-length human cystatin F cDNA in a pcDNA-DHFR expression vector as described previously (16). Cysteine mutants were constructed at amino acids C26 and C63 by exchanging the Cys to Ser as described previously (16). Glycosylation mutants were constructed at amino acids N61, N62, N115S or combinations therein by exchanging Asn to Ser using the following primers: N62S, CAGTGTTGAAAAGTTCAACTCCTGCACGAACGACATGTTCTTGTTC and GAACAAGAACATGTCGTTCGTGCAGGAGTTGAACTTTTCAACACTG; N61,62S, CAGTGTTGAAAAGTTCAGCTCCTGCACGAACGACATGTTCTTGTTC and GAACAAGAACATGTCGTTCGTGCAGGAGCTGAACTTTTCAACACTG and N115S, GACTTCCAAACCAGCCACACCTTGAAGCAGACTCTGAGCTGCTAC and GTAGCAGCTCAGAGTCTGCTTCAAGGTGTGGCTGGTTTGGAAGTC. Underline denotes substituted residues. All mutagenesis was performed using the Quik Change Site-Directed Mutagenesis kit. Glycosylation of cystatin F was assessed by treating cell lysates, conditioned medium or immunoprecipitated cystatin F with PNGase to remove the entire glycan or EndoH to selectively remove high mannose forms of the glycans according to manufacturer's guidelines.
###end p 58
###begin title 59
Transfection, transduction and protease assays
###end title 59
###begin p 60
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 553 554 553 554 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 576 577 576 577 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 586 587 586 587 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 591 592 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 177 182 <span type="species:ncbi:9606">Human</span>
###xml 214 220 <span type="species:ncbi:10090">murine</span>
293T cells were transfected with plasmids containing either full-length (wild type) or mutant cystatin F following manufacturer's instructions (Lipofectamine 2000; Invitrogen). Human cystatin F was transduced into murine L929 and L cells using the retroviral vector pBMN-I-GFP (Addgene, originally from G. Nolan, Stanford) as described previously (16). Transduced and transfected cells were left in culture for 48 h after which cystatin F-enriched medium and cells were separated by centrifugation. Cells were washed and lysed in buffer containing 100 mmcitrate, pH 5.4, 150 mmNaCl, 2 mmMgCl2 and 1% Triton-X-100. Culture media and cell lysates were analyzed for cystatin F expression by western blot using antibodies directed against the whole protein (FL Ab) unless otherwise noted. Protein concentrations in cell lysates were quantified by Bio-Rad Protein Assay (Bio-Rad). Equivalent concentrations of cystatin F in culture medium were determined by western blot and normalized before internalization assays, as described below.
###end p 60
###begin p 61
###xml 229 230 229 230 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 265 266 265 266 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 326 327 326 327 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 336 337 336 337 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 373 374 373 374 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 387 388 387 388 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Cathepsin activities were determined from 293T or L929 cell lysates following transfection or incubation with cystatin F-enriched media, as described below. Ten micrograms of postnuclear cell lysates was assayed using either 50 mmH-Gly-Phe-AMC (cathepsin C) or 40 mmZ-Phe-Arg-AMC (cathepsin L) in assay buffer containing 150 mmNaCl, 2 mmethylenediaminetetraacetic acid, 5 mmDTT and 100 mmcitrate, pH 5.5. All fluorometric assays were performed on a FLUOstar Optima Fluorimeter (BMG) reading excitation at 360 nm and emission at 460 nm. Cathepsin activity in 293T cells (cathepsin C) and L929 cells (cathepsin L) are expressed as the rate of AMC release over time.
###end p 61
###begin title 62
Size exclusion chromatography
###end title 62
###begin p 63
###xml 262 263 262 263 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 596 597 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sub>
###xml 619 620 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 620 622 620 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">av</sub>
###xml 653 654 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 654 656 654 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">av</sub>
###xml 660 661 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 661 662 661 662 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sub>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 666 667 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 670 671 670 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 671 672 671 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 675 676 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 676 677 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 686 687 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 687 688 687 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sub>
###xml 742 743 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 743 744 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 788 789 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 789 790 789 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 793 794 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 794 795 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 811 812 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 925 926 910 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 926 928 911 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">av</sub>
###xml 929 932 914 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sup>
###xml 932 936 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">(48)</xref>
Stokes' radius determination of wild-type dimeric cystatin F, C26,63S cystatin F and standard proteins were performed by size exclusion chromatography using an Amersham HiLoad 26/60 Superdex 75 column (Amersham Pharmacia). The column was pre-equilibrated in 50 mmphosphate buffer and 0.15 M NaCl, pH 7.2. Protein was loaded in 0.8 mL of equilibration buffer in detergent-free conditions at a flow rate of 0.5 mL/min at room temperature on the AKTA fast protein liquid chromatography system (Amersham Pharmacia) collecting 1 mL fractions. The elution volumes of cystatin F and standard proteins (Ve) were converted into Kav using the following equation; Kav = (Ve - Vo)/(Vc - Vo), where Vo is the void volume as determined by blue dextran and Vc is the calculated geometric column volume (Vc = r2product operatorL). The Stokes' radius of cystatin F was determined using a linear calibration plot of stokes' radii versus (-log Kav)1/2(48) obtained from standard proteins with known molecular weight and stokes' radii; ribonuclease A (13.7 kDa, 1.64 nm), carbonic anhydrase (29k Da, 2.43 nm), ovalbumin (43 kDa, 3.05 nm) and conalbumin (75 kDa, 3.57 nm as calculated).
###end p 63
###begin title 64
Radiolabeling
###end title 64
###begin p 65
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 128 130 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 263 265 261 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 475 477 467 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 754 758 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 858 862 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 868 871 860 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 963 966 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
For [35S] labeling, transfected 293T cells were preincubated in Met/Cys-free media (Sigma), labeled for 45 min with 0.4 mCi/mL [35S] Met/Cys (MP Biomedical) and chased for 3 h in complete RPMI-medium containing 100 mug/mL methionine and 500 mug/mL cysteine. For [32P] orthophosphate labeling, transfected 293T cells were incubated for 30 min at 37degreesC in phosphate-free MEM containing 10% dialyzed FCS and for another 4 h in the same medium supplemented with 0.5 mCi/mL [32P] orthophosphate (Perkin Elmer). Culture medium was removed and cells were washed extensively and then lysed in buffer containing 1% Triton-X-100. Radiolabeled cystatin F from culture medium and lysates were immunoprecipitated using cystatin F antibodies (FL Ab) as described (16). Aliquots of immunoprecipitated cystatin F were left untreated or digested with EndoH as described (16). For 125I-labeling experiments, 20 mug of purified recombinant cystatin F was labeled with 0.5 mCi [125I]-Na (Amersham) using the IODO-GEN reagent (Pierce) following manufacturer's instructions.
###end p 65
###begin title 66
Internalization assay
###end title 66
###begin p 67
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 304 305 304 305 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 502 505 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 553 554 552 553 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 804 805 791 792 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1045 1046 1026 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1163 1165 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1166 1168 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 1182 1183 1163 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1207 1208 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1244 1245 1225 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1035 1041 <span type="species:ncbi:10090">murine</span>
###xml 1144 1148 <span type="species:ncbi:10090">mice</span>
###xml 1230 1234 <span type="species:ncbi:10090">mice</span>
###xml 1269 1273 <span type="species:ncbi:10090">mice</span>
To follow the internalization of cystatin F, L929 cells were cultured at 5 x 105/mL in 10-cm culture dishes or 2 x 105 on glass coverslips for 24 h followed by the addition of normalized cystatin F supernatants taken from 293T cultures for an additional 24-48 h. The cells were then washed twice in 100 mmglycine, pH 3.0, lysed and analyzed for cystatin F internalization or cathepsin activity as described below. For studies using [125I]-labeled cystatin F, L929 cells were incubated with 500 mug/mL [125I] cystatin F in the presence or absence of 10 mmM6P at 4degreesC. The cells were washed three times with PBS to remove unbound protein and incubated at 37degreesC for 30 min to allow for internalization. Before lysis, cystatin F remaining on the plasma membrane was removed by acid stripping (100 mmglycine, pH 3.0). Control cells were maintained at 0degreesC throughout. Percent internalization was determined by dividing the acid stable fraction following acid washing at 30 min from the acid labile fraction at 0 min. Primary murine CD8+ T lymphocytes (CTL) and dendritic cells were isolated from the spleen and bone marrow of C57Bl/6 mice as described (16,47). Primary CD8+ splenocytes from CD45.2+, cystatin F knockout mice or CD45.1+, cystatin F-expressing mice were either cultured independently or at a 1:1 ratio for 48 h. Surface co-labeling of CD45.1 (fluorescein isothiocyanate) and CD45.2 (APC) were detected by flow cytometry using directly conjugated antibodies. Internalization of cystatin F was determined by surface staining of either CD45.1 (APC) or CD45.2 (APC) followed by intracellular staining for cystatin F (FL Ab) using the Fix & Perm cell permeabilization kit (Caltag Laboratories).
###end p 67
###begin title 68
Microscopy
###end title 68
###begin p 69
###xml 42 43 42 43 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 387 388 387 388 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 882 885 882 885 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lsm</sc>
###xml 199 205 <span type="species:ncbi:9986">rabbit</span>
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
###xml 261 266 <span type="species:ncbi:9940">sheep</span>
###xml 595 601 <span type="species:ncbi:9986">rabbit</span>
###xml 635 640 <span type="species:ncbi:9940">sheep</span>
###xml 704 709 <span type="species:ncbi:10090">mouse</span>
Transfected 293T cells were grown on poly-l-lysine-coated coverslips for 48 h before staining. Cells were then fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton-X-100 and costained with rabbit anti-cystatin F (FL Ab), and either mouse anti-CD63 or sheep anti-TGN46 in the presence of 1% (w/v) BSA as described (16). For internalization assays, L929 cells were grown on poly-l-lysine-coated coverslips for 18 h and treated with cystatin F-containing conditioned media or control media as described above. Primary antibodies were detected using Alexa-488 or Alexa-594-conjugated anti-rabbit (Invitrogen), TR-conjugated anti-sheep (pseudo-colored green) (Jackson Laboratory) and Alexa-488 anti-mouse (Invitrogen) secondary antibodies. Stained cells were mounted on glass slides and imaged on a LSM 510 META confocal microscope using a 100x PlanFluar/NA 1.45 objective and lsm510 software (Carl Zeiss Inc.) followed by processing with Photoshop (Adobe).
###end p 69
###begin p 70
We thank T. Braulke, R. Pohlmann and B. Hoflack for generous gifts of MPR knockout and reconstituted cell lines. We also thank S. van Kasteren and A.W. Schuttelkopf for helpful discussion. This work was supported by a Wellcome Trust Programme Grant to C. W.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Cystatins
###end article-title 72
###begin article-title 73
The role of cystatins in cells of the immune system
###end article-title 73
###begin article-title 74
###xml 49 53 <span type="species:ncbi:10090">mice</span>
A null mutation in the cystatin M/E gene of ichq mice causes juvenile lethality and defects in epidermal cornification
###end article-title 74
###begin article-title 75
###xml 37 44 <span type="species:ncbi:9031">chicken</span>
The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases
###end article-title 75
###begin article-title 76
###xml 57 62 <span type="species:ncbi:9606">human</span>
The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction
###end article-title 76
###begin article-title 77
Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases
###end article-title 77
###begin article-title 78
Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site
###end article-title 78
###begin article-title 79
Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells
###end article-title 79
###begin article-title 80
###xml 29 34 <span type="species:ncbi:9606">human</span>
Cystatin F is a glycosylated human low molecular weight cystein proteinase inhibitor
###end article-title 80
###begin article-title 81
Cystatin F is secreted, but artificial modification of its C-terminus can induce its endocytic targeting
###end article-title 81
###begin article-title 82
Inhibitory properties of cystatin F and its localization in U937 promonocyte cells
###end article-title 82
###begin article-title 83
###xml 54 59 <span type="species:ncbi:9606">human</span>
Structural basis of reduction-dependent activation of human cystatin F
###end article-title 83
###begin article-title 84
###xml 69 74 <span type="species:ncbi:9606">human</span>
Regulated expression and intracellular localization of cystatin F in human U937 cells
###end article-title 84
###begin article-title 85
FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor
###end article-title 85
###begin article-title 86
Demonstration of multiple novel glycoforms of the stem cell survival factor CCg
###end article-title 86
###begin article-title 87
Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis
###end article-title 87
###begin article-title 88
Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo
###end article-title 88
###begin article-title 89
Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis
###end article-title 89
###begin article-title 90
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice
###end article-title 90
###begin article-title 91
###xml 102 107 <span type="species:ncbi:9606">human</span>
Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor
###end article-title 91
###begin article-title 92
###xml 26 31 <span type="species:ncbi:9606">human</span>
Multiple dimeric forms of human CD69 result from differential addition of N-glycans to typical (Asn-X-Ser/Thr) and atypical (Asn-X-cys) glycosylation motifs
###end article-title 92
###begin article-title 93
Mannose 6-phosphate receptors: new twists in the tale
###end article-title 93
###begin article-title 94
Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation
###end article-title 94
###begin article-title 95
###xml 152 157 <span type="species:ncbi:9606">human</span>
Identification of full-sized forms of salivary (S-type) cystatins (cystatin SN, cystatin SA, cystatin S, and two phosphorylated forms of cystatin S) in human whole saliva and determination of phosphorylation sites of cystatin S
###end article-title 95
###begin article-title 96
###xml 70 75 <span type="species:ncbi:9606">human</span>
Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases
###end article-title 96
###begin article-title 97
###xml 101 106 <span type="species:ncbi:9606">human</span>
Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages
###end article-title 97
###begin article-title 98
Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass
###end article-title 98
###begin article-title 99
###xml 36 41 <span type="species:ncbi:9606">human</span>
Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease
###end article-title 99
###begin article-title 100
Colocalization of cystatin M/E and cathepsin V in lamellar granules and corneodesmosomes suggests a functional role in epidermal differentiation
###end article-title 100
###begin article-title 101
###xml 10 15 <span type="species:ncbi:9606">human</span>
Towards a human repertoire of monocytic lysosomal proteins
###end article-title 101
###begin article-title 102
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific
###end article-title 102
###begin article-title 103
The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein
###end article-title 103
###begin article-title 104
###xml 17 22 <span type="species:ncbi:9606">human</span>
Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin
###end article-title 104
###begin article-title 105
###xml 97 102 <span type="species:ncbi:9606">human</span>
Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-l-iduronidase, by cultured human fibroblasts
###end article-title 105
###begin article-title 106
The rate of internalization of the mannose 6-phosphate/insulin-like growth factor II receptor is enhanced by multivalent ligand binding
###end article-title 106
###begin article-title 107
Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells
###end article-title 107
###begin article-title 108
Megalin-mediated endocytosis of cystatin C in proximal tubule cells
###end article-title 108
###begin article-title 109
###xml 117 120 <span type="species:ncbi:10116">rat</span>
Endocytosis of beta-N-acetylglucosaminidase from sections of mucolipidosis-II and-III fibroblasts by non-parenchymal rat liver cells
###end article-title 109
###begin article-title 110
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 60 63 <span type="species:ncbi:10116">rat</span>
Recognition of human urine alpha-N-acetylglucosaminidase by rat hepatocytes. Involvement of receptors specific for galactose, mannose 6-phosphate and mannose
###end article-title 110
###begin article-title 111
Expression of a mannosyl-fucosyl receptor for endocytosis on cultured primary macrophages and their hybrids
###end article-title 111
###begin article-title 112
Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells
###end article-title 112
###begin article-title 113
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis
###end article-title 114
###begin article-title 115
###xml 33 38 <span type="species:ncbi:9606">human</span>
Internalization of cystatin C in human cell lines
###end article-title 115
###begin article-title 116
Thymocyte expression of cathepsin L is essential for NKT cell development
###end article-title 116
###begin article-title 117
Neither type of mannose 6-phosphate receptor is sufficient for targeting of lysosomal enzymes along intracellular routes
###end article-title 117
###begin article-title 118
Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling
###end article-title 118
###begin article-title 119
Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases
###end article-title 119
###begin title 120
Supporting Information
###end title 120
###begin p 121
Additional Supporting Information may be found in the online version of this article:
###end p 121
###begin title 122
Figure S1: Cystatin F inhibitory activity depends on proper subcellular localization
###end title 122
###begin p 123
293T cells were left alone or transfected with either wild-type cystatin F or various glycosylation mutants. Cathepsin C activity was determined using 10 mug of total protein from cell lysates. Data represent the mean rate of cathpesin C activity from two independent experiments.
###end p 123
###begin title 124
Figure S2: Internalization of cystatin F is not inhibited in the presence of free mannose or fucose
###end title 124
###begin p 125
Equal concentrations of secreted wild-type cystatin F produced by 293T cells were cultured with L929 cells for 48 h in the absence (untreated) or presence of 10 mM of the free sugars indicated. L929 cell lysates were separated by SDS-PAGE under nonreducing conditions and blots stained for internalized cystatin F (Cyst. F)
###end p 125
###begin title 126
Figure S3: Amino acid sequence alignment of cystatin F N-terminal glycosylation motifs
###end title 126
###begin p 127
###xml 306 317 306 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 306 317 <span type="species:ncbi:7955">Danio rerio</span>
Partial cystatin F sequence alignments were performed using Geneious Basic (Biomatters Ltd) as described. Amino acids 50-72 and 105-130 (human numbering) are displayed. Nonconsensus N-linked glycosylation motifs (NXC) are shown in red, while consensus sequences (NXS/T) are shown in blue. The sequence for Danio rerio was found to be incomplete.
###end p 127
###begin title 128
Figure S4: Internalization and activation of exogenously added cystatin F in cystatin F-deficient splenocytes
###end title 128
###begin p 129
###xml 91 92 90 91 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
A) Knockout splenocytes were treated either with a medium control (white fill) or with 5 mum of recombinant cystatin F (gray fill) for 48 h followed by intracellular cystatin F staining by FACS analysis, (B) intracellular cystatin F staining by confocal microscopy (green punctate stain) or (C) cathepsin C activity in postnuclear cell lysates. Data are from protein equivalents and are the mean rate from two independent experiments. Bars, 10 mum.
###end p 129
###begin p 130
Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
###end p 130

